<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>CurrentAnesthesia — Haemodynamics, fluids &amp; transfusion</title>
<subtitle>The newest Briefs placed in Haemodynamics, fluids &amp; transfusion.</subtitle>
<id>https://currentanesthesia.com/topics/haemodynamics-fluids-transfusion/feed.xml</id>
<link rel="self" type="application/atom+xml" href="https://currentanesthesia.com/topics/haemodynamics-fluids-transfusion/feed.xml"/>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/topics/haemodynamics-fluids-transfusion/"/>
<updated>2026-10-28T04:50:19.556Z</updated>
<author><name>CurrentAnesthesia</name><uri>https://currentanesthesia.com/topics/haemodynamics-fluids-transfusion/</uri></author>
<entry>
<title>Tranexamic acid and blood loss in pancreaticoduodenectomy: TAC-PD randomized clinical trial</title>
<id>https://currentanesthesia.com/studies/tac-pd-tranexamic-acid-and-blood-loss-in-pancreaticoduodenectomy-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/tac-pd-tranexamic-acid-and-blood-loss-in-pancreaticoduodenectomy-2022/"/>
<published>2026-10-28T04:50:19.556Z</published>
<updated>2026-10-28T04:50:19.556Z</updated>
<summary>Randomised controlled trial · Br J Surg, 2022. Intraoperative blood loss: TXA mean 659 ml · Placebo mean 701 ml</summary>
</entry>
<entry>
<title>Should Cell Salvage Be Used in Liver Resection and Transplantation? A Systematic Review and Meta-analysis</title>
<id>https://currentanesthesia.com/studies/should-cell-salvage-be-used-in-liver-resection-and-transplantation-a-systematic-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/should-cell-salvage-be-used-in-liver-resection-and-transplantation-a-systematic-2022/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Meta-analysis · Ann Surg, 2022. Allogeneic RBC transfusion, liver transplant — IBSA vs Control: mean difference -1.81 (95% CI -3.22, -0.40); P =0.01; I 2 =86%, very-low certainty</summary>
</entry>
<entry>
<title>Transfusion-free Strategies in Liver and Pancreatic Surgery: A Predictive Model of Blood Conservation for Transfusion Avoidance in Mainstream Populations</title>
<id>https://currentanesthesia.com/studies/transfusion-free-strategies-in-liver-and-pancreatic-surgery-a-predictive-model-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/transfusion-free-strategies-in-liver-and-pancreatic-surgery-a-predictive-model-2022/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Cohort study · Ann Surg, 2022. Perioperative outcomes of transfusion-free liver and pancreatic resections: Liver 7.0%; Clavien grade ≥3 morbidity 7.0% · Pancreas 15.9%; Clavien grade ≥3 morbidity 15.9%</summary>
</entry>
<entry>
<title>The time cost of physiologically ineffective intravenous fluids in the emergency department: an observational pilot study employing wearable Doppler ultrasound</title>
<id>https://currentanesthesia.com/studies/the-time-cost-of-physiologically-ineffective-intravenous-fluids-in-the-emergency-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-time-cost-of-physiologically-ineffective-intravenous-fluids-in-the-emergency-2023/"/>
<published>2026-10-28T04:36:50.728Z</published>
<updated>2026-10-28T04:36:50.728Z</updated>
<summary>Cohort study · J Intensive Care, 2023. Time spent providing ineffective IV fluid: Total hours across all 51 patients spent providing ineffective IV fluid 29.75</summary>
</entry>
<entry>
<title>Echocardiographic assessment of pulmonary capillary wedge pressure by E/e' ratio: A systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/echocardiographic-assessment-of-pulmonary-capillary-wedge-pressure-by-e-e-ratio-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/echocardiographic-assessment-of-pulmonary-capillary-wedge-pressure-by-e-e-ratio-2023/"/>
<published>2026-10-28T04:33:02.462Z</published>
<updated>2026-10-28T04:33:02.462Z</updated>
<summary>Meta-analysis · J Crit Care, 2023. Correlation between E/e' and PCWP: Weighted average correlation (r), pooled analysis: modest correlation between E/e' and PCWP 0.43 (95% CI 0.37-0.48)</summary>
</entry>
<entry>
<title>Physiological and linical ffects of ifferent nfusion ates of ntravenous luids for olume xpansion: A coping eview</title>
<id>https://currentanesthesia.com/studies/physiological-and-linical-ffects-of-ifferent-nfusion-ates-of-ntravenous-luids-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/physiological-and-linical-ffects-of-ifferent-nfusion-ates-of-ntravenous-luids-2023/"/>
<published>2026-10-28T04:33:02.462Z</published>
<updated>2026-10-28T04:33:02.462Z</updated>
<summary>Research article · J Crit Care, 2023. Physiological and clinical effects: Slower infusion: lower mortality (studies) 2</summary>
</entry>
<entry>
<title>Association Between Length of Storage of Transfused Packed RBC Units and Outcome of Surgical Critically Ill Adults: A Subgroup Analysis of the Age of Blood Evaluation Randomized Trial*</title>
<id>https://currentanesthesia.com/studies/association-between-length-storage-transfused-packed-rbc-units-outcome-surgical-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-length-storage-transfused-packed-rbc-units-outcome-surgical-2022/"/>
<published>2026-10-28T04:21:38.918Z</published>
<updated>2026-10-28T04:21:38.918Z</updated>
<summary>Secondary analysis · Crit Care Med, 2022. All-cause mortality, 90 days: Fresh 29.7% · Standard 28.4%</summary>
</entry>
<entry>
<title>Disparities in Unilateral Do Not Resuscitate Order Use During the COVID-19 Pandemic*</title>
<id>https://currentanesthesia.com/studies/disparities-in-unilateral-do-not-resuscitate-order-use-during-the-covid-19-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/disparities-in-unilateral-do-not-resuscitate-order-use-during-the-covid-19-2023/"/>
<published>2026-10-28T04:21:38.918Z</published>
<updated>2026-10-28T04:21:38.918Z</updated>
<summary>Cross-sectional study · Crit Care Med, 2023. unilateral do-not-resuscitate (UDNR) order use: DNR orders placed 41% (n = 604/1,473)</summary>
</entry>
<entry>
<title>Lower Versus Higher Exposure to Vasopressor Therapy in Vasodilatory Hypotension: A Systematic Review With Meta-Analysis*</title>
<id>https://currentanesthesia.com/studies/lower-versus-higher-exposure-to-vasopressor-therapy-in-vasodilatory-hypotension-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/lower-versus-higher-exposure-to-vasopressor-therapy-in-vasodilatory-hypotension-2022/"/>
<published>2026-10-28T04:21:38.918Z</published>
<updated>2026-10-28T04:21:38.918Z</updated>
<summary>Meta-analysis · Crit Care Med, 2022. All-cause mortality, 90 days — Lower exposure vs Higher exposure: RR 0.94 (95% CI 0.87-1.02); moderate certainty, lowered for imprecision</summary>
</entry>
<entry>
<title>Mean Arterial Pressure Targets and Patient-Important Outcomes in Critically Ill Adults: A Systematic Review and Meta-Analysis of Randomized Trials*</title>
<id>https://currentanesthesia.com/studies/mean-arterial-pressure-targets-and-patient-important-outcomes-in-critically-ill-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/mean-arterial-pressure-targets-and-patient-important-outcomes-in-critically-ill-2022/"/>
<published>2026-10-28T04:21:38.918Z</published>
<updated>2026-10-28T04:21:38.918Z</updated>
<summary>Meta-analysis · Crit Care Med, 2022. Mortality — Higher MAP vs Lower MAP: RR 1.06 (95% CI 0.98-1.15); p = 0.12; I2 = 0%</summary>
</entry>
<entry>
<title>Comparison of clinical outcomes between aggressive and non-aggressive intravenous hydration for acute pancreatitis: a systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/comparison-clinical-outcomes-between-aggressive-non-aggressive-intravenous-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-clinical-outcomes-between-aggressive-non-aggressive-intravenous-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Meta-analysis · Crit Care, 2023. All-cause mortality — Aggressive vs Non-aggressive: pooled RR 2.45 (95% CI 1.37, 4.40); severe AP</summary>
</entry>
<entry>
<title>Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trial</title>
<id>https://currentanesthesia.com/studies/fluid-balance-control-in-critically-ill-patients-results-from-poincare-2-stepped-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/fluid-balance-control-in-critically-ill-patients-results-from-poincare-2-stepped-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Randomised controlled trial · Crit Care, 2023. All-cause mortality, 60 days: Strategy 129 (30.5% (95% CI 26.2-34.8)) · Control 160 (33.9% (95% CI 29.6-38.2))</summary>
</entry>
<entry>
<title>Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study</title>
<id>https://currentanesthesia.com/studies/point-of-care-diagnosis-and-monitoring-of-fibrinolysis-resistance-in-the-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/point-of-care-diagnosis-and-monitoring-of-fibrinolysis-resistance-in-the-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Cohort study · Crit Care, 2023. Ex vivo response to supplementation (TPA-test lysis time): Distinct response groups: increased fibrinolysis after supplementation with (i) t-PA only or (ii) plasminogen and t-PA</summary>
</entry>
<entry>
<title>A novel smartphone app for blood pressure measurement: a proof-of-concept study against an arterial catheter</title>
<id>https://currentanesthesia.com/studies/a-novel-smartphone-app-for-blood-pressure-measurement-a-proof-of-concept-study-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/a-novel-smartphone-app-for-blood-pressure-measurement-a-proof-of-concept-study-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Research article · J Clin Monit Comput, 2022. Agreement of app vs invasive BP — OptiBP vs Invasive BP: bias ± SD 0.0 ± 7.5 mmHg (95% limits of agreement CI - 14.9, 14.8); SBP</summary>
</entry>
<entry>
<title>Does the age of packed red blood cells, donor sex or sex mismatch affect the sublingual microcirculation in critically ill intensive care unit patients? A secondary interpretation of a retrospective analysis</title>
<id>https://currentanesthesia.com/studies/does-age-packed-red-blood-cells-donor-sex-or-sex-mismatch-affect-sublingual-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/does-age-packed-red-blood-cells-donor-sex-or-sex-mismatch-affect-sublingual-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Secondary analysis · J Clin Monit Comput, 2022. ∆PPV: Fresh Mean + 8.8% (IQR - 0.5 to 22.5) · Medium Mean 5.5% (IQR 0.1 to 10.1) · Old Mean + 4.7% (IQR - 2.1 to 6.5)</summary>
</entry>
<entry>
<title>Echocardiographic hemodynamic assessment in decompensated cirrhosis: comparison between Intensivists and Gastroenterologists</title>
<id>https://currentanesthesia.com/studies/echocardiographic-hemodynamic-assessment-in-decompensated-cirrhosis-comparison-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/echocardiographic-hemodynamic-assessment-in-decompensated-cirrhosis-comparison-2023/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2023. Inter-rater agreement and reliability: Limits of agreement, subaortic VTI - 6.6 to 7.2 cm</summary>
</entry>
<entry>
<title>Interaction Between Platelet and Fibrinogen on Clot Strength in Healthy Patients</title>
<id>https://currentanesthesia.com/studies/interaction-between-platelet-and-fibrinogen-on-clot-strength-in-healthy-patients-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/interaction-between-platelet-and-fibrinogen-on-clot-strength-in-healthy-patients-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. PLT vs thromboelastography maximum amplitude (TEG-MA): Correlation PLT and TEG-MA (univariate), r 0.88; p &lt; 0.0001</summary>
</entry>
<entry>
<title>Prognostic Model for Vasopressor Requirement After Retroperitoneal Adrenalectomy for Pheochromocytoma: A Retrospective Study</title>
<id>https://currentanesthesia.com/studies/prognostic-model-for-vasopressor-requirement-after-retroperitoneal-adrenalectomy-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/prognostic-model-for-vasopressor-requirement-after-retroperitoneal-adrenalectomy-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Postoperative vasopressor requirement — Baseline coronary artery disease (CAD): OR 6.21 (95% CI 2.48-15.52); p = 0.0001</summary>
</entry>
<entry>
<title>Mesenteric traction syndrome — Incidence, impact, and treatment: A systematic scoping review of the literature</title>
<id>https://currentanesthesia.com/studies/mesenteric-traction-syndrome-incidence-impact-and-treatment-a-systematic-scoping-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/mesenteric-traction-syndrome-incidence-impact-and-treatment-a-systematic-scoping-2022/"/>
<published>2026-10-28T03:54:35.559Z</published>
<updated>2026-10-28T03:54:35.559Z</updated>
<summary>Research article · Anaesth Crit Care Pain Med, 2022. Combined incidence of MTS during open abdominal surgery: MTS incidence 76%</summary>
</entry>
<entry>
<title>Haemoglobin levels and outcomes of subgroups of patients with pre‐operative anaemia based on red cell size: A retrospective cohort study</title>
<id>https://currentanesthesia.com/studies/haemoglobin-levels-and-outcomes-of-subgroups-of-patients-with-pre-operative-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/haemoglobin-levels-and-outcomes-of-subgroups-of-patients-with-pre-operative-2023/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2023. Pre-operative anaemia subgroups by red cell size: Microcytic 1089 (10.4%) · Normocytic 9243 (88.0%) · Macrocytic 173 (1.6%)</summary>
</entry>
<entry>
<title>Intra‐operative blood transfusion in elderly patients on antithrombotic therapy</title>
<id>https://currentanesthesia.com/studies/intra-operative-blood-transfusion-in-elderly-patients-on-antithrombotic-therapy-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/intra-operative-blood-transfusion-in-elderly-patients-on-antithrombotic-therapy-2023/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Secondary analysis · Acta Anaesthesiol Scand, 2023. Intra-operative transfusion of packed RBC: Antithrombotic therapy 191 (4.7%) · No antithrombotic therapy 98 (3.2%)</summary>
</entry>
<entry>
<title>Issuing of isotonic crystalloid solutions to Danish public hospitals in 2021—A retrospective nationwide observational study</title>
<id>https://currentanesthesia.com/studies/issuing-of-isotonic-crystalloid-solutions-to-danish-public-hospitals-in-2021-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/issuing-of-isotonic-crystalloid-solutions-to-danish-public-hospitals-in-2021-a-2022/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2022. Isotonic crystalloid solutions issued nationally, 2021: Total issued 1,487,144 L</summary>
</entry>
<entry>
<title>Use of vasoactive agents in non‐cardiac surgery: Protocol for a scoping review</title>
<id>https://currentanesthesia.com/studies/use-of-vasoactive-agents-in-non-cardiac-surgery-protocol-for-a-scoping-review-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/use-of-vasoactive-agents-in-non-cardiac-surgery-protocol-for-a-scoping-review-2022/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Research article · Acta Anaesthesiol Scand, 2022. Planned overview of indications, agents used and outcomes assessed for vasoactive agents in non-cardiac surgery</summary>
</entry>
<entry>
<title>Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/viscoelastic-conventional-coagulation-tests-reduce-blood-product-transfusion-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/viscoelastic-conventional-coagulation-tests-reduce-blood-product-transfusion-2022/"/>
<published>2026-10-28T03:35:32.861Z</published>
<updated>2026-10-28T03:35:32.861Z</updated>
<summary>Meta-analysis · Eur J Anaesthesiol, 2022. Transfused units per blood product — VETs vs CCTs: mean difference -1.40 RBC units (95% CI -1.87 to -0.92); P &lt; 0.001; I2 = 61%</summary>
</entry>
<entry>
<title>Improving Patient Blood Management Programs: An Implementation Science Approach</title>
<id>https://currentanesthesia.com/studies/improving-patient-blood-management-programs-an-implementation-science-approach-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/improving-patient-blood-management-programs-an-implementation-science-approach-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Research article · Anesth Analg, 2022. Practical implementation guidance on key clinical, administrative, leadership and structural elements for safe, comprehensive delivery of care in PBM programs at the local level</summary>
</entry>
<entry>
<title>Incidence of Postreperfusion Hyperfibrinolysis in Liver Transplantation by Donor Type and Observed Treatment Strategies</title>
<id>https://currentanesthesia.com/studies/incidence-of-postreperfusion-hyperfibrinolysis-in-liver-transplantation-by-donor-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/incidence-of-postreperfusion-hyperfibrinolysis-in-liver-transplantation-by-donor-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2022. Hyperfibrinolysis after reperfusion: DBD 16 (3.1%) · DCD 5 (27.8%) · Living donors 0 (0.0%)</summary>
</entry>
<entry>
<title>The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery ( PREVENTT ) trial</title>
<id>https://currentanesthesia.com/studies/association-between-iron-deficiency-outcomes-secondary-analysis-intravenous-iron-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-iron-deficiency-outcomes-secondary-analysis-intravenous-iron-2022/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Secondary analysis · Anaesthesia, 2022. Blood transfusion or death and number of blood transfusions, by baseline iron status subgroup, 30 days: IV iron vs placebo did not differentially reduce death or blood transfusion across subgroups by ferritin (interaction P) p = 0.33</summary>
</entry>
<entry>
<title>Effect of pneumatic leg compression on post‐induction hypotension in elderly patients undergoing robot‐assisted laparoscopic prostatectomy: a double‐blind randomised controlled trial</title>
<id>https://currentanesthesia.com/studies/effect-pneumatic-leg-compression-post-induction-hypotension-elderly-undergoing-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-pneumatic-leg-compression-post-induction-hypotension-elderly-undergoing-2023/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Randomised controlled trial · Anaesthesia, 2023. Incidence of post-induction hypotension (SBP &lt; 90 mmHg during the first 20 min after induction), first 20 min after induction: Pneumatic leg compression 5 (10%) · Control 29 (58%)</summary>
</entry>
<entry>
<title>The safety of tranexamic acid administration in total knee arthroplasty: a population‐based study from Taiwan</title>
<id>https://currentanesthesia.com/studies/the-safety-of-tranexamic-acid-administration-in-total-knee-arthroplasty-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-safety-of-tranexamic-acid-administration-in-total-knee-arthroplasty-a-2022/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Cohort study · Anaesthesia, 2022. Blood transfusion — TXA vs No TXA: RR 0.50 (95% CI 0.48-0.51); 50% decrease</summary>
</entry>
<entry>
<title>Endotypes of intraoperative hypotension during major abdominal surgery: a retrospective machine learning analysis of an observational cohort study</title>
<id>https://currentanesthesia.com/studies/endotypes-of-intraoperative-hypotension-during-major-abdominal-surgery-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/endotypes-of-intraoperative-hypotension-during-major-abdominal-surgery-a-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Secondary analysis · Br J Anaesth, 2022. Intraoperative hypotension endotypes: Episodes of intraoperative hypotension 615</summary>
</entry>
<entry>
<title>Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS)</title>
<id>https://currentanesthesia.com/studies/recommendations-from-the-international-consensus-conference-on-anemia-management-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/recommendations-from-the-international-consensus-conference-on-anemia-management-2022/"/>
<published>2026-10-27T23:40:12.801Z</published>
<updated>2026-10-27T23:40:12.801Z</updated>
<summary>Guideline or statement · Ann Surg, 2022.</summary>
</entry>
<entry>
<title>Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial</title>
<id>https://currentanesthesia.com/studies/balanced-crystalloid-solution-saline-deceased-donor-kidney-transplantation-best-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/balanced-crystalloid-solution-saline-deceased-donor-kidney-transplantation-best-2023/"/>
<published>2026-10-27T23:36:21.661Z</published>
<updated>2026-10-27T23:36:21.661Z</updated>
<summary>Randomised controlled trial · Lancet, 2023. DGF: Balanced crystalloid 121 (30%) · Saline 160 (40%)</summary>
</entry>
<entry>
<title>Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia</title>
<id>https://currentanesthesia.com/studies/platelet-transfusion-before-cvc-placement-in-patients-with-thrombocytopenia-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/platelet-transfusion-before-cvc-placement-in-patients-with-thrombocytopenia-2023/"/>
<published>2026-10-27T23:35:39.811Z</published>
<updated>2026-10-27T23:35:39.811Z</updated>
<summary>Randomised controlled trial · N Engl J Med, 2023. Catheter-related bleeding of grade 2 to 4: Transfusion 9 (4.8%) · No transfusion 22 (11.9%)</summary>
</entry>
<entry>
<title>Tranexamic Acid vs Adrenaline for Controlling Iatrogenic Bleeding During Flexible Bronchoscopy: A Double-Blind Randomized Controlled Trial</title>
<id>https://currentanesthesia.com/studies/tranexamic-acid-vs-adrenaline-for-controlling-iatrogenic-bleeding-during-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/tranexamic-acid-vs-adrenaline-for-controlling-iatrogenic-bleeding-during-2022/"/>
<published>2026-10-27T23:33:56.230Z</published>
<updated>2026-10-27T23:33:56.230Z</updated>
<summary>Randomised controlled trial · Chest, 2022. Bleeding stopped: Adrenaline 54 (83.1%) · TXA 54 (83.1%)</summary>
</entry>
<entry>
<title>Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials</title>
<id>https://currentanesthesia.com/studies/optimal-dosing-heparin-prophylactic-anticoagulation-critically-ill-covid-19-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/optimal-dosing-heparin-prophylactic-anticoagulation-critically-ill-covid-19-2023/"/>
<published>2026-10-27T23:28:00.394Z</published>
<updated>2026-10-27T23:28:00.394Z</updated>
<summary>Meta-analysis · J Crit Care, 2023. Mortality — Escalated dose vs Standard thromboprophylaxis: RR 1.01 (95% CI 0.90-1.13); no significant impact</summary>
</entry>
<entry>
<title>Right ventricular echocardiographic parameters and prediction of stroke volume in ischemic cardiogenic shock: A retrospective study</title>
<id>https://currentanesthesia.com/studies/right-ventricular-echocardiographic-parameters-and-prediction-of-stroke-volume-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/right-ventricular-echocardiographic-parameters-and-prediction-of-stroke-volume-2022/"/>
<published>2026-10-27T23:28:00.394Z</published>
<updated>2026-10-27T23:28:00.394Z</updated>
<summary>Cohort study · J Crit Care, 2022. Correlation with SV: RVOT VTI correlated best to SV r = 0.39 p = 0.01</summary>
</entry>
<entry>
<title>Advances in the Management of Cardiogenic Shock</title>
<id>https://currentanesthesia.com/studies/advances-in-the-management-of-cardiogenic-shock-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/advances-in-the-management-of-cardiogenic-shock-2023/"/>
<published>2026-10-27T23:20:28.165Z</published>
<updated>2026-10-27T23:20:28.165Z</updated>
<summary>Research article · Crit Care Med, 2023. CS results in short-term mortality exceeding 30% despite standard therapy</summary>
</entry>
<entry>
<title>Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis*</title>
<id>https://currentanesthesia.com/studies/angiotensin-ii-for-the-treatment-of-refractory-shock-a-matched-analysis-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/angiotensin-ii-for-the-treatment-of-refractory-shock-a-matched-analysis-2023/"/>
<published>2026-10-27T23:20:28.165Z</published>
<updated>2026-10-27T23:20:28.165Z</updated>
<summary>Cohort study · Crit Care Med, 2023. 30-day mortality, 30 days: Angiotensin II 60% · Control 56%</summary>
</entry>
<entry>
<title>Noninvasive Monitoring of Arterial Pressure: Finger or Lower Leg As Alternatives to the Upper Arm: A Prospective Study in Three ICUs</title>
<id>https://currentanesthesia.com/studies/noninvasive-monitoring-of-arterial-pressure-finger-or-lower-leg-as-alternatives-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/noninvasive-monitoring-of-arterial-pressure-finger-or-lower-leg-as-alternatives-2023/"/>
<published>2026-10-27T23:20:28.165Z</published>
<updated>2026-10-27T23:20:28.165Z</updated>
<summary>Cohort study · Crit Care Med, 2023. Agreement for mean AP (bias): Lower leg bias 6.0 ± 15.8 mm Hg · Upper bias 3.6 ± 7.1 mm Hg · Finger bias 0.1 ± 7.4 mm Hg</summary>
</entry>
<entry>
<title>Sodium Bicarbonate for Metabolic Acidosis in the ICU: Results of a Pilot Randomized Double-Blind Clinical Trial</title>
<id>https://currentanesthesia.com/studies/sodium-bicarbonate-for-metabolic-acidosis-in-the-icu-results-of-a-pilot-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/sodium-bicarbonate-for-metabolic-acidosis-in-the-icu-results-of-a-pilot-2023/"/>
<published>2026-10-27T23:20:28.165Z</published>
<updated>2026-10-27T23:20:28.165Z</updated>
<summary>Randomised controlled trial · Crit Care Med, 2023. Hours alive and free of vasopressor, day 7: Sodium bicarbonate median 132.2 (IQR 85.6-139.1) hours · Placebo median 97.1 (IQR 69.3-132.4) hours</summary>
</entry>
<entry>
<title>Correlation between the VExUS score and right atrial pressure: a pilot prospective observational study</title>
<id>https://currentanesthesia.com/studies/correlation-between-the-vexus-score-and-right-atrial-pressure-a-pilot-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/correlation-between-the-vexus-score-and-right-atrial-pressure-a-pilot-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Cohort study · Crit Care, 2023. Association between RAP and VExUS grade: Significant positive association between RAP and VExUS grade (adjusted for age, sex, common comorbidities), P &lt; 0.001 R2 = .68</summary>
</entry>
<entry>
<title>Diagnostic accuracy of point-of-care ultrasound for shock: a systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/diagnostic-accuracy-of-point-of-care-ultrasound-for-shock-a-systematic-review-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/diagnostic-accuracy-of-point-of-care-ultrasound-for-shock-a-systematic-review-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Meta-analysis · Crit Care, 2023. Pooled sensitivity and specificity (95% CI): Obstructive shock: sensitivity 0.82 (0.68-0.91); specificity 0.98 (0.92-0.99); positive likelihood ratio 40 (11-105) · Cardiogenic shock: sensitivity 0.78 (0.56-0.91); specificity 0.96 (0.92-0.98) · Hypovolemic shock: sensitivity 0.90 (0.84-0.94); specificity 0.92 (0.88-0.95) · Distributive shock: sensitivity 0.79 (0.71-0.85); specificity 0.96 (0.91-0.98)</summary>
</entry>
<entry>
<title>Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial</title>
<id>https://currentanesthesia.com/studies/initiating-angiotensin-ii-at-lower-vasopressor-doses-in-vasodilatory-shock-an-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/initiating-angiotensin-ii-at-lower-vasopressor-doses-in-vasodilatory-shock-an-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Secondary analysis · Crit Care, 2023. 28-day survival, adjusted for severity of illness, by baseline NED subgroup, 28 days: Low-NED subgroup: AT II half as likely to die at 28 days vs placebo</summary>
</entry>
<entry>
<title>The increase in cardiac output induced by a decrease in positive end-expiratory pressure reliably detects volume responsiveness: the PEEP-test study</title>
<id>https://currentanesthesia.com/studies/peep-test-the-increase-in-cardiac-output-induced-by-a-decrease-in-positive-end-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/peep-test-the-increase-in-cardiac-output-induced-by-a-decrease-in-positive-end-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Diagnostic or prognostic study · Crit Care, 2023. PEEP-test (CI increase &gt; 8.6%) for detecting volume responsiveness: PEEP-test: sensitivity 96.8% (95%CI: 83.3-99.9%); specificity 84.9% (95%CI 68.1-94.9%); AUC 0.94 (95%CI 0.85-0.98) (p &lt; 0.0001 vs. 0.5)</summary>
</entry>
<entry>
<title>Variation in central venous oxygen saturation to evaluate fluid responsiveness: a systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/variation-in-central-venous-oxygen-saturation-to-evaluate-fluid-responsiveness-a-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/variation-in-central-venous-oxygen-saturation-to-evaluate-fluid-responsiveness-a-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Meta-analysis · Crit Care, 2023. Diagnostic performance for fluid responsiveness: ΔScvO2: AUHSROC 0.86 (95% CI 0.83-0.89); pooled sensitivity 0.78 (95% CI 0.69-0.85); pooled specificity 0.84 (95% CI 0.72-0.91); pooled diagnostic OR 17.7 (95% CI 5.9-53.2)</summary>
</entry>
<entry>
<title>Direct assessment of microcirculation in shock: a randomized-controlled multicenter study</title>
<id>https://currentanesthesia.com/studies/direct-assessment-of-microcirculation-in-shock-a-randomized-controlled-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/direct-assessment-of-microcirculation-in-shock-a-randomized-controlled-2023/"/>
<published>2026-10-27T23:13:02.241Z</published>
<updated>2026-10-27T23:13:02.241Z</updated>
<summary>Randomised controlled trial · Intensive Care Med, 2023. 30-day mortality, 30 days: 30-day mortality did not differ</summary>
</entry>
<entry>
<title>Bioimpedance based determination of cardiac index does not show enough trueness for point of care use in patients with systolic heart failure</title>
<id>https://currentanesthesia.com/studies/bioimpedance-based-determination-of-cardiac-index-does-not-show-enough-trueness-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/bioimpedance-based-determination-of-cardiac-index-does-not-show-enough-trueness-2023/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2023. CO agreement, TBI vs thermodilution (all patients): Mean bias for CO 0.3 L/min</summary>
</entry>
<entry>
<title>Blood pressure control with phenylephrine or dobutamine: a randomized controlled trial comparing effects on cerebral and paravertebral tissue oxygen saturation measured with near-infrared spectroscopy</title>
<id>https://currentanesthesia.com/studies/blood-pressure-control-phenylephrine-or-dobutamine-randomized-controlled-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/blood-pressure-control-phenylephrine-or-dobutamine-randomized-controlled-2023/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Randomised controlled trial · J Clin Monit Comput, 2023. Paravertebral tissue saturation (rSpvO2): No significant changes at the paravertebral level in either group; slight but statistically significant difference between groups at T3-T4 and L1-L2</summary>
</entry>
<entry>
<title>Carotid flow as a surrogate of the left ventricular stroke volume</title>
<id>https://currentanesthesia.com/studies/carotid-flow-as-a-surrogate-of-the-left-ventricular-stroke-volume-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/carotid-flow-as-a-surrogate-of-the-left-ventricular-stroke-volume-2022/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Agreement of carotid VTI with LVOT VTI — CS VTI vs LVOT VTI: Spearman's correlation coefficient 0.81 (95% CI 0.67-0.89)</summary>
</entry>
<entry>
<title>Diuretics depletion improves cardiac output and ventriculo-arterial coupling in congestive ICU patients during hemodynamic de-escalation</title>
<id>https://currentanesthesia.com/studies/diuretics-depletion-improves-cardiac-output-and-ventriculo-arterial-coupling-in-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/diuretics-depletion-improves-cardiac-output-and-ventriculo-arterial-coupling-in-2023/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2023. Cardiac index after vs before diuretics, 24 h: Congestive mean 2.7 ± 0.8 L min- 1 m- 2; baseline 2.5 ± 0.8 L min- 1 m- 2; P vs baseline p = 0.042 · Non-congestive mean 2.7 ± 0.7 L min- 1 m- 2; baseline 2.7 ± 0.8 L min- 1 m- 2; P vs baseline p = 0.968</summary>
</entry>
</feed>
